Drug Manufacturers - General
Compare Stocks
2 / 10Stock Comparison
SCLX vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
SCLX vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - General | Drug Manufacturers - Specialty & Generic |
| Market Cap | $56M | $1.61B |
| Revenue (TTM) | $40M | $4.18B |
| Net Income (TTM) | $-376M | $-1.82B |
| Gross Margin | 68.6% | 34.2% |
| Operating Margin | -6.5% | -4.1% |
| Forward P/E | 2.6x | 5.6x |
| Total Debt | $38M | $3.97B |
| Cash & Equiv. | $3M | $532M |
SCLX vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Scilex Holding Comp… (SCLX) | 100 | 2.3 | -97.7% |
| Perrigo Company plc (PRGO) | 100 | 29.0 | -71.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCLX vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SCLX is the clearest fit if your priority is growth exposure.
- Rev growth 21.1%, EPS growth 56.7%, 3Y rev CAGR 21.8%
- 21.1% revenue growth vs PRGO's -2.8%
- Lower P/E (2.6x vs 5.6x)
PRGO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- -77.7% 10Y total return vs SCLX's -97.7%
- Lower volatility, beta 1.18, current ratio 2.76x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.1% revenue growth vs PRGO's -2.8% | |
| Value | Lower P/E (2.6x vs 5.6x) | |
| Quality / Margins | -43.5% margin vs SCLX's -9.3% | |
| Stability / Safety | Beta 1.18 vs SCLX's 2.50 | |
| Dividends | 9.8% yield; 10-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +74.4% vs PRGO's -51.2% | |
| Efficiency (ROA) | -19.8% ROA vs SCLX's -136.2% |
SCLX vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SCLX vs PRGO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — SCLX and PRGO each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 103.5x SCLX's $40M. Profitability is closely matched — net margins range from -43.5% (PRGO) to -9.3% (SCLX). On growth, PRGO holds the edge at -7.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $40M | $4.2B |
| EBITDAEarnings before interest/tax | -$259M | $58M |
| Net IncomeAfter-tax profit | -$376M | -$1.8B |
| Free Cash FlowCash after capex | $24M | $108M |
| Gross MarginGross profit ÷ Revenue | +68.6% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -6.5% | -4.1% |
| Net MarginNet income ÷ Revenue | -9.3% | -43.5% |
| FCF MarginFCF ÷ Revenue | +59.0% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.8% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -17.3% | -56.4% |
Valuation Metrics
Evenly matched — SCLX and PRGO each lead in 2 of 4 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $56M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $91M | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.41x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 2.59x | 5.56x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.42x |
| Price / SalesMarket cap ÷ Revenue | 0.99x | 0.38x |
| Price / BookPrice ÷ Book value/share | — | 0.55x |
| Price / FCFMarket cap ÷ FCF | 2.89x | 11.12x |
Profitability & Efficiency
SCLX leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), SCLX scores 6/9 vs PRGO's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -50.7% |
| ROA (TTM)Return on assets | -136.2% | -19.8% |
| ROICReturn on invested capital | — | +3.7% |
| ROCEReturn on capital employed | — | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 1.35x |
| Net DebtTotal debt minus cash | $35M | $3.4B |
| Cash & Equiv.Liquid assets | $3M | $532M |
| Total DebtShort + long-term debt | $38M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -39.55x | -7.20x |
Total Returns (Dividends Reinvested)
PRGO leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRGO five years ago would be worth $3,986 today (with dividends reinvested), compared to $231 for SCLX. Over the past 12 months, SCLX leads with a +74.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors PRGO at -25.2% vs SCLX's -64.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -38.6% | -13.5% |
| 1-Year ReturnPast 12 months | +74.4% | -51.2% |
| 3-Year ReturnCumulative with dividends | -95.5% | -58.1% |
| 5-Year ReturnCumulative with dividends | -97.7% | -60.1% |
| 10-Year ReturnCumulative with dividends | -97.7% | -77.7% |
| CAGR (3Y)Annualised 3-year return | -64.5% | -25.2% |
Risk & Volatility
PRGO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PRGO is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than SCLX's 2.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRGO currently trades 41.2% from its 52-week high vs SCLX's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 1.18x |
| 52-Week HighHighest price in past year | $34.27 | $28.44 |
| 52-Week LowLowest price in past year | $3.92 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +23.5% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 59.3 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 55K | 3.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates SCLX as "Buy" and PRGO as "Hold". PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | — | $20.00 |
| # AnalystsCovering analysts | 2 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | +9.8% |
| Dividend StreakConsecutive years of raises | — | 10 |
| Dividend / ShareAnnual DPS | — | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
PRGO leads in 2 of 6 categories (Total Returns, Risk & Volatility). SCLX leads in 1 (Profitability & Efficiency). 2 tied.
SCLX vs PRGO: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SCLX or PRGO a better buy right now?
For growth investors, Scilex Holding Company (SCLX) is the stronger pick with 21.
1% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Analysts rate Scilex Holding Company (SCLX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SCLX or PRGO?
Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -60.
1%, compared to -97. 7% for Scilex Holding Company (SCLX). Over 10 years, the gap is even starker: PRGO returned -77. 7% versus SCLX's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SCLX or PRGO?
By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.
18β versus Scilex Holding Company's 2. 50β — meaning SCLX is approximately 112% more volatile than PRGO relative to the S&P 500.
04Which is growing faster — SCLX or PRGO?
By revenue growth (latest reported year), Scilex Holding Company (SCLX) is pulling ahead at 21.
1% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Scilex Holding Company grew EPS 56. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, SCLX leads at 21. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SCLX or PRGO?
Perrigo Company plc (PRGO) is the more profitable company, earning -33.
5% net margin versus -128. 7% for Scilex Holding Company — meaning it keeps -33. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -147. 4% for SCLX. At the gross margin level — before operating expenses — SCLX leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is SCLX or PRGO more undervalued right now?
On forward earnings alone, Scilex Holding Company (SCLX) trades at 2.
6x forward P/E versus 5. 6x for Perrigo Company plc — 3. 0x cheaper on a one-year earnings basis.
07Which pays a better dividend — SCLX or PRGO?
In this comparison, PRGO (9.
8% yield) pays a dividend. SCLX does not pay a meaningful dividend and should not be held primarily for income.
08Is SCLX or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
18), 9. 8% yield). Scilex Holding Company (SCLX) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, SCLX: -97. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SCLX and PRGO?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SCLX is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while SCLX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.